Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jan;12(1):16-23.
Epub 2019 Jan 1.

Role, Extent, and Impact of Comorbidity on Prognosis and Survival in Advanced Metastatic Melanoma: A Review

Frederick N Bebe  1   2   3 , Shasa Hu  1   2   3 , Tony L Brown  1   2   3 , Orien L Tulp  1   2   3
Affiliations
Review

Role, Extent, and Impact of Comorbidity on Prognosis and Survival in Advanced Metastatic Melanoma: A Review

Frederick N Bebe et al. J Clin Aesthet Dermatol. 2019 Jan.

Abstract

Increased incidence of comorbidity in advanced metastatic melanoma (AMM) is emerging as an important factor in patient prognosis, treatment, and survival. This paper reviews the impact of comorbidities on the prognosis and survival outcomes of patients diagnosed with AMM. Our search initially yielded limited results. We then broadened our search to include breast, colorectal, and prostate cancer and covered malignancies in which screening (like melanoma) is associated with the detection of early-stage disease. Most studies showed that a higher prevalence of comorbidity was associated with more advanced cancer stage. Both treatment and survival of patients were influenced by age and the extent of comorbidity. Racial differences in survival were greatest for patients with no comorbidities and less evident at higher levels of comorbidity. Comorbid conditions showed differential effects for prognosis, treatment, and survival. Limited Information in the literature demonstrates that more research is warranted with respect to comorbidities and AMM.

Keywords: Comorbidity; advanced metastatic melanoma; prognosis; race/ethnicity; survival.

PubMed Disclaimer

Conflict of interest statement

FUNDING:No funding was received for this study. DISCLOSURES:The authors have no conflicts of interest relevant to the content of this article.

Figures

FIGURE 1.
FIGURE 1.
Interactions between comorbidity and age, socioeconomic factors, race/ethnicity, frailty, and functional status. Adapted from Sarfati D et al.
FIGURE 2.
FIGURE 2.
Article exclusion/inclusion flowchart.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Extermann M, Overcash J, Lyman GH et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol. 1998;16(04):1582–1587. - PubMed
    1. Extermann M. Interaction between comorbidity and cancer. Cancer Control. 2007;14(01):13–22. - PubMed
    1. Read WL, Tierney RM, Page NC et al. Differential diagnostic impact of comorbidity. J Clin Oncol. 2004;22(15):3099–3103. - PubMed
    1. Gurney J, Sarfati D, Stanley J. The impact of patient comorbidity on cancer stage at diagnosis. Br J Cancer. 2015;113(09):1375–1380. - PMC - PubMed
    1. Gonzalez EC, Ferrante JM, Van Durme et al. Comorbid illness and early detection of cancer. Southern Med J. 2001;94(09):913–919. - PubMed

LinkOut - more resources